Vivos is a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for the treatment of non resectable tumors. The Company is engaged in the development of RadioGel, an Yttrium-90 based brachytherapy device, for the treatment of tumors.